Guardant Health EPS GH
Diluted earnings per share by quarter and over the last twelve months, from 2017.
- Last 12 months, to Jun 30, 2026
- −$3.49
- Latest quarter, Q2 FY26
- −$0.90
- Fiscal year 2025
- −$3.31
Guardant Health's earnings per share was −$3.49 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.90.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$3.31 | n/a |
| FY2024 | −$3.56 | n/a |
| FY2023 | −$4.28 | n/a |
| FY2022 | −$6.41 | n/a |
| FY2021 | −$4.00 | n/a |
| FY2020 | −$2.58 | n/a |
| FY2019 | −$0.84 | n/a |
| FY2018 | −$5.15 | n/a |
| FY2017 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.90 | n/a | −$3.49 | |
| Q1 FY26 | −$0.85 | n/a | −$3.39 | |
| Q4 FY25 | −$1.00 | n/a | −$3.31 | |
| Q3 FY25 | −$0.74 | n/a | −$3.21 | |
| Q2 FY25 | −$0.80 | n/a | −$3.35 | |
| Q1 FY25 | −$0.77 | n/a | −$3.39 | |
| Q4 FY24 | −$0.90 | n/a | −$3.56 | |
| Q3 FY24 | −$0.88 | n/a | −$4.24 | |
| Q2 FY24 | −$0.84 | n/a | −$4.09 | |
| Q1 FY24 | −$0.94 | n/a | −$3.92 | |
| Q4 FY23 | −$1.58 | n/a | −$4.28 | |
| Q3 FY23 | −$0.73 | n/a | −$4.07 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Guardant Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| GHGuardant Health | −$3.49 | |
| LHLabcorp | $12.09 | +33% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| MEDPMedpace | $17.05 | +27% a year |
| RVTYRevvity | $2.10 | −11% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| ILMNIllumina | $5.38 | −32% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| WATWaters | $4.01 | −64% a year |
| IQVIQVIA | $8.06 | +17% a year |
| AAgilent Technologies | $5.09 | +19% a year |
| Peer median | $8.73 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Guardant Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.